What's new

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025

Jun 4, 2025 - 11:00
 0
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025
Read More

Tags:

Previous Article

Draft guideline on the clinical investigation of human normal immunoglobulin for...

Next Article

Minutes of the PRAC meeting 07-10 April 2025

Related Posts

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

List of medicines currently in PRIME scheme

Jun 2, 2025  0